EpiVax
About:
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Website: http://www.epivax.com
Twitter/X: EpiVax
Top Investors: National Institutes of Health, Slater Technology Fund, GBS/CIDP Foundation International
Description:
EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.
Total Funding Amount:
$6.64M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Providence, Rhode Island, United States
Founded Date:
1998-01-01
Contact Email:
admin(AT)epivax.com
Founders:
Anne S. De Groot, Annie De Groot
Number of Employees:
11-50
Last Funding Date:
2022-09-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai